| |
| |
|
| Insider
Information: |
Powers Bradley J |
| Relationship: |
General Counsel |
| City: |
Ames |
| State: |
IA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
6,307 |
|
|
Indirect Shares
|
27 |
|
|
| Direct
Value |
$15,641 |
|
|
|
Indirect Value
|
$67 |
|
|
| Total
Shares |
6,334 |
|
|
| Total
Value |
$15,708 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Lumos Pharma Inc |
LUMO |
General Counsel |
2024-04-01 |
6,307 |
2024-04-01 |
27 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LUMO |
Lumos Pharma Inc |
General Counsel |
• – – |
2024-04-01 |
4 |
D |
$2.84 |
$971 |
D/D |
(342) |
6,307 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
General Counsel |
• – – |
2024-04-01 |
4 |
A |
$2.84 |
$2,556 |
D/D |
900 |
6,649 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
General Counsel |
• – – |
2024-02-01 |
4 |
D |
$3.01 |
$722 |
D/D |
(240) |
5,749 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
General Counsel |
• – – |
2023-02-01 |
4 |
D |
$3.52 |
$461 |
D/D |
(131) |
6,331 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
General Counsel |
• – – |
2023-02-01 |
4 |
A |
$3.52 |
$3,168 |
D/D |
900 |
6,462 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
General Counsel |
• – – |
2022-04-01 |
4 |
D |
$9.23 |
$3,157 |
D/D |
(342) |
5,562 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
General Counsel |
• – – |
2022-02-01 |
4 |
D |
$10.02 |
$782 |
D/D |
(78) |
5,904 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
General Counsel |
• – – |
2022-02-01 |
4 |
A |
$10.02 |
$9,018 |
D/D |
900 |
5,982 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
General Counsel |
• – – |
2021-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
869 |
5,424 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
General Counsel |
• – – |
2020-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
4,555 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Principal Executive Officer |
• – – |
2019-08-24 |
4 |
D |
$1.59 |
$121 |
D/D |
(76) |
503 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Principal Executive OfficerOff |
• – – |
2019-08-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
250 |
|
- |
|
| LUMO |
Lumos Pharma Inc |
Principal Executive OfficerOff |
• – – |
2019-08-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
579 |
|
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
